At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
PET/CT scan to assess treatment efficacydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Tracer Positron Emission Tomography (PET) Prediction and Assessment of Response to Gemcitabine in Pancreatic Cancer Patients
In Brief
A clinical study evaluating PET/CT scan to assess treatment efficacy for Pancreatic Cancer. Completed, enrolled 9 participants across 1 site.
Detailed Summary
Study of multi-tracer PET scans to assess response to gemcitabine in pancreatic cancer
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Cancer
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 2014
Enrollment StartDec 2014
Primary CompletionMar 2016
TodayJul 2026
First PostedSep 19, 2014
Enrollment StartDec 12, 2014
Primary CompletionMar 17, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.8 years ago
Interventions
PET/CT scan to assess treatment efficacydevice